Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Notice of Results

1 Feb 2022 09:23

RNS Number : 3008A
Indivior PLC
01 February 2022
 

 

 

 

Indivior to Announce FY 2021 Results and Host a Presentation on February 16th

Slough, UK, and Richmond, VA, February 1, 2022 - Indivior PLC (LON: INDV) today announced that it will release its FY 2021 results on February 16th at 7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indivior.com.

Mark Crossley, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 13:00 GMT (8:00 a.m. U.S. Eastern) on February 16th.

Access to the Live Webcast Presentation

The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins.

The webcast link is: https://edge.media-server.com/mmc/p/8tao6fad

Participants may access the presentation telephonically:

· US participants 1-646-741-3167

· International participants +44 (0) 2071-928338

 

Please reference confirmation ID 8268632. A replay of the presentation will be available at www.indivior.com.

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.

Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior. 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOREANAFEAEAEEA
Date   Source Headline
25th Jul 20257:00 amRNSIndivior Announces Completion of London Delisting
24th Jul 20253:52 pmRNSHolding(s) in Company
24th Jul 20258:34 amRNSHolding(s) in Company
23rd Jul 20258:08 amRNSHolding(s) in Company
21st Jul 20254:23 pmRNSHolding(s) in Company
21st Jul 20258:33 amRNSHolding(s) in Company
18th Jul 20258:35 amRNSHolding(s) in Company
17th Jul 20252:00 pmRNSNotice of Results
1st Jul 20258:46 amRNSHolding(s) in Company
1st Jul 20258:43 amRNSHolding(s) in Company
1st Jul 20258:37 amRNSHolding(s) in Company
1st Jul 20258:34 amRNSHolding(s) in Company
1st Jul 20257:49 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSIndivior Announces Inclusion in US Russell Indexes
25th Jun 20257:00 amRNSIndivior Appoints Tony Kingsley to the Board
17th Jun 20254:42 pmRNSHolding(s) in Company
13th Jun 20258:10 amRNSDirector/PDMR Shareholding - Correction
12th Jun 20254:24 pmRNSDirector/PDMR Shareholding
10th Jun 20254:12 pmRNSHolding(s) in Company
6th Jun 20254:49 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSIndivior Announces Intent to Cancel LSE Listing
15th May 20253:30 pmRNSDirector/PDMR Shareholding
13th May 20253:00 pmRNSIndivior to Participate in Upcoming Events
9th May 20254:37 pmRNSAmendment to Result of AGM
8th May 20252:31 pmRNSBlock listing Interim Review
8th May 20252:00 pmRNSResult of AGM
6th May 20251:48 pmRNSDirector/PDMR Shareholding
1st May 20259:21 amRNSTotal Voting Rights
24th Apr 20257:00 amRNS1st Quarter Results
22nd Apr 20251:58 pmRNSHolding(s) in Company
10th Apr 20254:51 pmRNSNotice of Results
3rd Apr 202512:31 pmRNSHolding(s) in Company
1st Apr 202511:19 amRNSTotal Voting Rights
28th Mar 20258:33 amRNSHolding(s) in Company
27th Mar 20252:00 pmRNSNotice of AGM
21st Mar 20253:40 pmRNSHolding(s) in Company
17th Mar 20251:25 pmRNSDirector/PDMR Shareholding
17th Mar 20251:17 pmRNSAnnual Financial Report
14th Mar 20253:44 pmRNSDirector/PDMR Shareholding
14th Mar 202510:03 amRNSHolding(s) in Company
11th Mar 202512:41 pmRNSDirector/PDMR Shareholding
11th Mar 202510:18 amRNSDirector/PDMR Shareholding
10th Mar 20255:39 pmRNSDirector/PDMR Shareholding
5th Mar 20252:02 pmRNSDirector/PDMR Shareholding
4th Mar 20251:45 pmRNSHolding(s) in Company
4th Mar 202511:23 amRNSDirector/PDMR Shareholding
4th Mar 202511:23 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSFurther Changes to Board of Directors
4th Mar 20257:00 amRNSIndivior PLC Files 2024 Annual Report on Form 10-K
3rd Mar 20259:29 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.